# A Folinic Acid Intervention for Autism Spectrum Disorders

> **NCT01602016** · PHASE2 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 99 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Autistic Disorder
- Autism
- Asperger's Syndrome
- Pervasive Development Disorders

## Interventions

- **DRUG:** Folinic Acid and placebo
- **DRUG:** Folinic Acid

## Key facts

- **NCT ID:** NCT01602016
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** Non-compliance
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602016, "A Folinic Acid Intervention for Autism Spectrum Disorders". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01602016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*